2. Five Things You Need to Know About Secondary Prevention Post-ACS

4. Baseline Characteristics – STEMI vs NSTEMI*

5. Long-Term Mortality: NSTEMI vs STEMI*

6. NSTEMI Discharge Medications*

7. PLATO: Secondary Efficacy Endpoints Over Time

8. ATLAS ACS 2-TIMI 51: Primary Efficacy Endpoint: Cardiovascular Death/MI/Stroke

9. Time to Non-Procedure-Related PLATO Major Bleeding

10. Post-MI FREEE: Design

11. Post-MI FREEE: Medication Adherence

12. Post-MI FREEE: Major Vascular Events Fatal or Nonfatal MI, Unstable Angina, CHF, Stroke

13. Five Things You Need to Know About Secondary Prevention Post-ACS